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Essential mechanisms of energy production, signaling, biosynthe-
sis and apoptosis are contained within mitochondria, and their
orchestration plays a determinant role in cell physiology [1,2]. Since
mitochondria generate between 80% and 90% of all ATP produced in
the cell, it is understandable that in tissues like the cardiac muscle
these organelles occupy 20–30% of the cell volume, having mitochon-
drial function, or dysfunction, a critical role in the performance of this
tissue [3]. In cardiomyocytes, like in skeletal muscle ﬁbers, there is the
added dimension of two mitochondria subpopulations located in
different regions of the cell: one abuts the sarcolemma (subsarco-
lemmal mitochondria, SS), and the other is trapped within the
contractile apparatus (intermyoﬁbrillar mitochondria, IMF) [4–6].
These mitochondrial subpopulations possess different properties,
which may contribute to their distinct capacities for adaptation to
different stimuli [4,6–10]. For instance, previous studies have
reported higher respiratory rates in IMF compared to SS in cardiactissue [6,7,11], which might be related with the levels of the
unwanted by-products of inefﬁcient electron transfer within mito-
chondria [10,12]. As major sources of reactive oxygen and nitrogen
species (RONS), mitochondria themselves, and particularly oxidative
phosphorylation (OXPHOS) complexes, are especially susceptible to
oxidative and nitrative damage [2,10,12]. Protein carbonylation is
considered to be a major form of protein oxidation, being widely
detected namely byWestern blot immunoassay [13]. Among themain
carbonyl products of metal-catalyzed oxidation of proteins are
glutamic and aminoadipic semialdehydes [15]. The assay of these
compounds involves derivatization of the carbonyl group with 2,4-
dinitrophenylhydrazine (DNPH), with formation of dinitrophenyl
(DNP) hydrazone product. DNPH also reacts with sulfenic acid,
resultant from cysteine oxidation, a modiﬁcation that regulates
protein function [13]. Western blot is also used for the search of
3-nitrotyrosine modiﬁcation, a hallmark of reactive nitrogen species
(RNS), generally associated with impaired functional and/or struc-
tural integrity of target proteins [14]. With the advancements in
proteomics technology it is now possible to identify relevant protein
targets of such posttranslational modiﬁcations (PTMs) in pathophys-
iological conditions like aging [16,17] or diabetes [7].
Although it has been veriﬁed that mitochondria subpopulations
have different functional emphases [6,10,11,18], the molecular
mechanisms underlying their discrete properties in cardiac tissue
are still poorly understood. As mitochondria comprise a primary locus
for the formation and reactions of RONS [10,12], functional differences
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least partially, a consequence of the distinct susceptibility of IMF and
SS mitochondrial proteins to oxidative modiﬁcations. In order to
verify our assumption, fractions of SS and IMF mitochondria were
isolated from heart tissue fromWistar rats following amethodological
procedure recently described for skeletal muscle [18], which
guarantees the high purity of mitochondrial subpopulations obtained.
2. Materials and methods
2.1. Chemicals
All reagents were obtained from Sigma-Aldrich (St. Louis, USA),
unless otherwise speciﬁed. Mouse monoclonal anti-3-nitrotyrosine
antibody was obtained from Chemicon (Temecula, CA, USA), rabbit
polyclonal anti-DNP antibody was obtained from DakoCytomation
(Hamburg, Germany), anti-ATPB antibody (cat. no. ab14730) was
obtained from Abcam (Cambridge, UK) and secondary peroxidase-
conjugated antibodies (anti-mouse IgG and anti-rabbit IgG) were
obtained from GE Healthcare (Buckinghamshire, UK).
2.2. Animals
Adult male Wistar rats (Charles River Laboratories, Barcelona,
Spain) with an age of 12–16 weeks were used in these experiments.
All procedures were performed in accordance with the Guide for the
Care and Use of Laboratory Animals. Twenty-ﬁve rats weighing
approximately 300 g were housed in collective cages before use. Out
of these 25 animals, groups of 5 rats were sacriﬁced at different points
of time within 2 weeks to have their heart muscle pooled for further
analysis. All samples were used to separate their mitochondria
subpopulations.
2.3. SS and IMF mitochondria isolation
Mitochondrial populations were puriﬁed from heart muscle
following the protocol described by our group for skeletal muscle
[18], which is based on tissue mechanical treatment and enzymatic
digestion as previously reported by Palmer et al. [11]. In brief, cardiac
tissue was minced with scissors in homogenization buffer (250 mM
sucrose, 10 mM Tris–HCl, 0.1 mM EGTA (pH 7.4)), supplemented with
2 mM PMSF and 0.25 mg/ml trypsin (Promega, Wisconsin, USA).
Following 10 minof incubation on ice, albumin fat-free was added to a
ﬁnal concentration of 10 mg/ml. The tissue was subsequently rinsed
three times with buffer and then homogenized with a Potter
homogenizer (Teﬂon pestle). Large cellular debris and nuclei were
pelleted by centrifuging for 5 min at 1000×g. Amitochondria enriched
fraction was obtained by centrifuging the supernatant for 20 min at
16,000×g and ressuspending the pellet in a small volume of
homogenization buffer. Pure mitochondrial subpopulations were
then obtained by ultracentrifugation at 95,000×g for 30 min on a
density-gradient with 50% (v/v) Percoll. Two brown bands were
observed; the lower band corresponded to IMF mitochondria while
the upper band corresponded to SS mitochondria [18]. The mito-
chondrial fractions were then washed twice and were aliquoted for
subsequent biochemical analysis. Protein content was determined
with RC DC Protein Assay kit (Bio-Rad, Hercules, CA, USA).
2.4. Respiratory chain complexes activity
Mitochondrial fractions were disrupted by a combination of freeze–
thawing in hypotonic media (25 mM potassium phosphate, pH 7.2) to
allow free access to substrates for all assays [19]. Complex I activity was
measured by following the reduction of 2,6-dichlorophenolindophenol
(DCIP) at 600 nm for 4 min, after which rotenone was added and the
absorbance was measured again for 4 min[20]. Complex II activity wasdetermined according to Birch-Machin et al. [21]. In brief, the enzyme
catalyzed reduction of DCIP was followed at 600 nm for 3 min after
addition of 65 μM ubiquinone. The antimycin A-sensitive complex III
activity was assayed at 550 nm as described [16]. The speciﬁc activity of
cytochrome coxidase was measured by following the oxidation of
cytochrome c (II) at 550 nm [21]. ATP synthase activity was measured
according to Simon et al. [22]. The phosphate produced by hydrolysis of
ATP reacts with ammonium molybdate in the presence of reducing
agents to form a blue-colour complex, the intensity of which is
proportional to the concentration of phosphate in solution. Oligomycin
was used as an inhibitor of mitochondrial ATPase activity.
2.5. Blue-native PAGE separation of mitochondria membrane complexes
BN-PAGE was performed using the method described by Schagger
and von Jagow [23] with minor modiﬁcations. Mitochondria (400 μg
of protein) from each subpopulation were pelleted by centrifugation
at 20,000×g for 10 min and then resuspended in solubilization buffer
(50 mM NaCl, 50 mM Imidazole, 2 mM ɛ-amino n-caproic acid, 1 mM
EDTA pH 7.0) with 1% (w/v) digitonin. After 10 min on ice, insoluble
material was removed by centrifugation at 20,000×g for 30 min at
4 °C. Soluble components were combined with 0.5% (w/v) Coomassie
Blue G250, 50 mM ɛ-amino n-caproic acid, 4% (w/v) glycerol and
separated on a 4–13% gradient acrylamide gradient gel with 3.5%
sample gel on top. Anode buffer contained 25 mM Imidazole pH 7.0.
Cathode buffer (50 mM tricine and 7.5 mM Imidazole pH 7.0)
containing 0.02% (w/v) Coomassie Blue G250 was used during 1 h
at 70 V, the time needed for the dye front reach approximately one-
third of the gel. Cathode buffer was then replaced with one containing
only 0.002% (w/v) Coomassie Blue G250 and the native complexes
were separated at 200 V for 4 h at 4 °C. A native protein standard
HMW-native marker (GE Healthcare, Buckinghamshire, UK) was
used. The gels were stained with Coomassie Colloidal for protein
visualization and scannedwith Gel Doc XR System (Bio-Rad, Hercules,
CA, USA). Band detection, quantiﬁcation and matching were
performed using QuantityOne Imaging software (v4.6.3, Bio-Rad).
2.6. In-gel activity of complexes IV and V
The in-gel activity and histochemical staining assays of complexes
IV and Vwere determined using themethods described by Zerbetto et
al. [24] with minor modiﬁcations. Complex IV-speciﬁc heme stain in
BN-PAGE gels was determined using 10 μl horse heart cytochrome c
(5 mM) and 0.5 mg diaminobenzidine (DAB) dissolved in 1 ml 50 mM
sodium-phosphate, pH 7.2. The reaction was stopped by 50% (v/v)
methanol, 10% (v/v) acetic acid, and the gels were then transferred to
water. ATP hydrolysis activity of complex V was analyzed by
incubating the native gels with 35 mM Tris, 270 mM glycine buffer,
pH 8.3 at 37 °C, that had been supplementedwith 14 mMMgSO4, 0.2%
(w/v) Pb(NO3)2, and 8 mM ATP. Lead phosphate precipitation that is
proportional to the enzymatic ATP hydrolysis activity was stopped by
50% (v/v) methanol (30 min), and the gels were then transferred to
water.
2.7. 2-D BN-PAGE separation of respiratory complexes subunits
Each lane of the ﬁrst dimension gel was excised and was
subsequently incubated in equilibration buffer (2% (w/v) SDS, 6 M
urea, 30% glycerol, 0.05 M Tris–HCl pH 8,8 and 20 mg/ml DTT) for
30 min at room temperature to induce dissociation of the protein
complexes. Next, the lanes were placed on top of a 4% stacking SDS gel
polymerized over a 5–20% gradient SDS-PAGE (18×16 cm) and this
gel was run at 100 V during 1 h and then at 200 V during 3–4 h. Gel
was stained with Coomassie Colloidal for protein visualization or was
blotted onto a nitrocellulose membrane (Whatman®, Protan®) for
subsequent 3-nitrotyrosine and carbonyl groups detection by
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(Bio-Rad, Hercules, CA, USA). Spot detection, quantiﬁcation and
matching were performed using PDQuest software (v8.0.1, Bio-Rad).
2.8. Western blotting analysis
Mitochondrial proteins separated by 2-D BN-PAGE were blotted on
a nitrocellulose membrane (Whatman®, Protan) in transfer buffer
(25 mM Tris, 192 mM glycine, pH 8.3 and 20% methanol) during 2 h
(200 mA). Then, nonspeciﬁc binding was blocked with 5% (w/v) dry
non fat milk in TBS-T (100 mM Tris, 1.5 mM NaCl, pH 8.0 and 0.5%
Tween 20) and themembrane was incubated with anti-3-nitrotyrosine
primary antibody solution (1:1000 dilution). After 2-h incubation, the
membrane waswashed with TBS-T and incubated with anti-mouse IgG
peroxidase-conjugated secondary antibody (1:1000 dilution).
Carbonylated proteins were assayed as previously described
[25,26], with some modiﬁcations. Brieﬂy, each lane of BN-PAGE was
incubated with 12% SDS by 30 min at room temperature. Then, the
lanes were derivatized with 20 mM DNPH/10% TFA. After 30 min in
the dark, the reactionwas stoppedwith equilibration buffer (2% (w/v)
SDS, 6 M urea, 30% glycerol, 0.05 M Tris–HCl pH 8,8 and 20 mg/ml
DTT) for 30 min at room temperature. The second dimension was
obtained as described in 2D-BN-PAGE section and proteins were
blotted onto a nitrocellulose membrane. Immunodetection of carbo-
nylated proteins was performed using rabbit anti-DNP as primary
antibody.
In order to validate gel data, the expression levels of ATPB were
also evaluated by Western blotting analysis. In brief, mitochondrial
proteins were separated by 12.5% SDS-PAGE, electrotransfered to a
nitrocellulose membrane and immunodetection was carried for ATPB.
Immunoreactive bands were detected by enhanced chemilumi-
nescence ECL (Amersham Pharmacia Biotech) according to the
manufacturer's procedure and images were recorded using X-ray
ﬁlms (Kodak Biomax light Film, Sigma). The ﬁlms and the gels were
scanned in Molecular Imager Gel Doc XR+System (Bio-Rad) and
analyzed with QuantityOne software (v 4.6.3 Bio-Rad). 2D-BN-PAGE
blot images were analyzed with the PDQuest software (version 8.0.1;
Bio-Rad). A matchset from 3 biological replicates was performed with
correlation coefﬁcient values of at least 0.8. To simplify the
experiment, blots images were cropped and ﬁtted to the same
dimension (65×58mm) for further analyses. Following automatic
spot detection, matching was performed. The image with the highest
number of spots was selected as the master gel. The spot boundary
tool was applied to detect large spots. The patterns in sections of the
blots in appropriate magniﬁcation were checked and spots were
added manually to the master image to allow matching unique spots
present in the individual blots. The spot quantity table containing all
matched spots was generated based on normalization of spot
intensity (density) per total intensity of all valid spots in each blot
image. In the case of carbonyl blot, the normalization was performed
taken in consideration the total background intensity. The quantity
table was exported to a spreadsheet .xls ﬁle and submitted to
statistical analyses.
2.9. Protein identiﬁcation by MALDI-TOF/TOF analysis
Spots from 2-D BN-PAGE were excised manually and in-gel tryptic
digestion was performed. In brief, the gel pieces were washed twice
with 25 mM ammonium bicarbonate/50% acetonitrile, followed by a
wash with 100% acetonitrile. They were then dried under vacuum in a
concentrator (SpeedVac® Plus SC 210A, Thermo Savant, NY, USA) and
21 μl of 10 μg/ml sequence-grade modiﬁed porcine trypsin in 25 mM
ammonium bicarbonate was added to the dried residues and
incubated overnight at 37 °C. The tryptic peptides were extracted
from the gel with formic acid and were then dried under vacuum and
re-suspended in 10 μl of a 50% acetonitrile/0.1% formic acid solution.Mass spectra was obtained on a matrix-assisted laser desorption/
ionization–time of ﬂight MALDI-TOF/TOF mass spectrometer (4800
Proteomics Analyzer, Applied Biosystems, Foster City, CA, USA) in the
positive ion reﬂector mode and obtained in the mass range from 700
to 4500 Da with 1000 laser shots. A data-dependent acquisition
method was created to select the ten most intense peaks in each
sample spot for subsequent tandemmass spectrometry (MS/MS) data
acquisition, excluding those from the matrix, due to trypsin autolysis
or acrylamide peaks. Trypsin autolysis peaks (m/z 842.5 and m/z
2211.1) were used for internal calibration of the mass spectra. Spectra
were processed and analyzed by the Global Protein Server Worksta-
tion (Applied Biosystems, Foster City, CA, USA), which uses internal
Mascot software (Matrix Science, London, UK) on searching the
peptide mass ﬁngerprinting (PMF) and MS/MS data. Searches were
performed against the Swiss-Prot nonredundant protein database
(peptide fragment ﬁngerprinting; rodents 18012009), allowing
oxidation of methionine and acrylamide adducts (propionamide) of
the cysteine residues as variable modiﬁcations. The peptide mass
tolerance was 30 ppm and fragment ion mass tolerance was 0.3 Da.
Protein identiﬁcations were considered as reliable when the MASCOT
score was N70 (MASCOT score was calculated as−10×log P, where P
is the probability that the observed match is a random event). This is
the lowest conﬁdence score for protein identiﬁcation indicated by the
program as signiﬁcant (pb0.05) and indicated by the probability of
incorrect protein identiﬁcation.2.10. Posttranslational modiﬁcations identiﬁcation by nLC-MALDI-MS/
MS
The protein digests corresponding to the spots identiﬁed in the 2D
Western blot maps were diluted to a ﬁnal concentration of 5%
acetonitrile and separated using an Ultimate 3000 (LCPackings) nano-
HPLC. Brieﬂy, the sample was washed over a C18 trapping column
(Zorbax 300SB-C18, 5 μm particle size, 5×0.3 mm, Agilent Technolo-
gies) for 5 min with 95% buffer A (water, 0.1% TFA), 5% Buffer B
(acetonitrile, 0.05% TFA) at a ﬂow rate of 300 nl/min. Flow was then
reversed over the trapping column, and sample was eluted onto a
150 mm×75 μm Zorbax 300SB capillary analytical C18 column with
3.5 μm particle size (Agilent Technologies) at a ﬂow rate of 300 nl/min.
A linear gradient of 5% Buffer B to 50% Buffer B was run over a period of
35 min. The columnwaswashedwith a 5 min gradient from 50% to 85%
Buffer B, followed by a 5-min hold at 85% Buffer B. The column was re-
equilibrated in 5% Buffer B prior to further analyses. Using the micro-
collector Probot (Dionex/LC Packings) and, after a lag time of 5 min,
peptides eluting from the capillary column were mixed with a
continuous ﬂow of α-CHCA matrix solution (270 nl/min, 2 mg/ml in
70% ACN/0.3% TFA and internal standard Glu-Fib at 15 ftmol) were
directly deposited onto the LC-MALDI plates at 20-second intervals for
each spot (100 nl/fraction). For every separation run, 156 fractions
were collected. TheMS analysis was performed using aMALDI-TOF/TOF
instrument. An S/N threshold of 50 was used to select peaks for MS/MS
analyses. A fragmentation voltage of 2 kV was used throughout the
automated runs.
Mass spectra were acquired and processed as described above.
Mascot has the limitation of allowing only 9 modiﬁcations per search.
Therefore, 6 independent searches were performed with a maximum
of 9 modiﬁcations each, in a total of 26 variable different modiﬁca-
tions. The following modiﬁcations targeted were oxidation (C, H, W,
D, K, N, P, F, Y, R, M), dioxidation (W, M, F, Y, C, P, R, K, N), nitration (Y,
W), nitrosilation (Y), nitrene insertion (Y), arginine oxidation to
glutamic semialdehyde and lysine oxidation to aminoadipic semi-
aldehyde. When a peptide presented different modiﬁcations in
different searches, it was submitted to a new search using the
combination of all the modiﬁcations identiﬁed for that same peptide,
to eliminate false positives.
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database was created for all SwissProt in 8% of FDR (false positive
peptides/(false positive peptides+total peptides))*100. Unique
peptides retrieved from FDR search were considered for PTM
characterization. Searched PTMs were considered as reliable when
the program indicated the MASCOT score as signiﬁcant (pb0.05) and
the individual ion score for each MS/MS spectra (calculated as
described above for protein search) was higher than 30. Further
validation of peptide modiﬁcations found was conducted using the
Paragon algorithm and the ProteinPilot 4.0 software (Applied
Biosystems, Foster City, CA, USA) to perform a new search. For
Paragon, PTMs were searched with a 95% conﬁdence interval for
protein identiﬁcations including two missed cleavages, biological
modiﬁcations and FDR. Proteins were identiﬁed based on the
presence of at least two unmodiﬁed peptides from the same protein
by the Pro Group algorithm at the 99% conﬁdence level. For PTM
analysis of each protein, modiﬁed peptide conﬁdence score cut-off N2
and 99 was used prior to manual inspection, if other peptides from
presented conﬁdence scores greater than 99. For Paragon searching
algorithm, the peptide identiﬁcation false positive rates were
estimated at less than 3% based on the number of forward to reversed
peptide hits.
Each PTM conﬁrmed by both searching procedures was further
manually validated.2.11. Statistical analysis
Optical densities of differentially expressed protein spots in
Western blots were exported from QuantityOne to SPSS (v15.0).
The Kolmogorov–Smirnov test was used to test normality of
distribution for all data (i.e., OXPHOS activity, gel and Western
blotting analysis). Since all variables were normally distributed,
signiﬁcant differences between the twomitochondrial subpopulations
were evaluatedwith the unpaired Student's t-test. A p valueb0.05was
considered signiﬁcant.Fig. 1. (A) BN-PAGE proﬁle of SS and IMF mitochondria. An overlap of the density variatio
staining of in-gel activity of complexes IV and V. On the right side is presented a semi-quan3. Results
3.1. Respiratory chain complexes organization and activity
To evaluate the effect of mitochondrial cell location on respiratory
chain complexes' organization, digitonin-solubilized membrane pro-
teins from SS and IMF fractions were resolved by BN-PAGE. As can be
depicted in Fig. 1A, the pattern of the ﬁve respiratory chain complexes
is consistent with the molecular weight described in the literature
[23]. No qualitative or quantitative differences of the overall band
pattern were observed among isolated IMF and SS mitochondria.
Western blotting analysis of ATP synthase subunit beta was
performed in order to validate the protein expression proﬁle observed
and no differences were observed among mitochondrial populations
(Fig. S1). Interestingly, the analysis of the in-gel activity of complexes
IV and V revealed higher activity levels in IMF mitochondria (Fig. 1).
Spectrophotometric quantiﬁcation of all respiratory chain complexes
supports this tendency (Table 2). Indeed, higher activity levels of
respiratory chain complexes II and IV were observed for IMF
mitochondria, with uppermost values noticed for cytochrome c
oxidase (1.6 fold, pb0.05). A tendency for increased activity in IMF
mitochondria was observed for complexes I, III (Table 2) and V (Fig. 1
and Table 2).
3.2. Protein susceptibility to nitration and carbonylation
The mitochondrial membrane proteins' susceptibility to carbon-
ylation and nitration was assessed by 2D-BN-PAGE followed by
Western blotting with anti-DNP or anti-3-nitrotyrosine antibodies,
respectively. A semi-quantitative comparative analysis of Western
blots obtained with both antibodies was performed using the volume
contour tool from the PDQuest software (Bio-Rad). As can be seen in
Fig. 2–D, IMF mitochondria were more susceptible to membrane
proteins nitration than SS whereas higher carbonylation levels were
observed in this subpopulation. The proteins in the spots correspond-
ing to carbonylated and/or nitrated proteins were further identiﬁedn for both lanes is presented on the right. (B) Representative image of histochemical
titative analysis of in-gel activity of both complexes. *pb0.05.
Fig. 2. Representative 2D maps for heart SS (A) and IMF (B) mitochondria are presented. A magniﬁed comparison of 2D Western blot for nitrated and carbonylated proteins is
presented in panel (C). Whole blot signal intensity was compared between mitochondrial subpopulations and signiﬁcant differences (pb0.05) were found (D). For numbering refer
to Table 1.
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preferential targets of these modiﬁcations (7 nitrated and 15
carbonylated). From these, 8 proteins were observed in 2D-BN-
PAGE spots corresponding to the predicted molecular weight.
Among the proteins with nitrated tyrosines were cytochrome b–c1
complex subunits 1 and 2 from complex III, ATP synthase subunits
alpha and beta from complex V (spots 1, 2, 3, 4 and 5; Fig. 2 and
Table 1), the tricarboxylic acid cycle enzymes, malate dehydrogenase
and isocitrate dehydrogenase [NAD] subunit alpha, and dihydrolipoyl
dehydrogenase, an enzyme of the pyruvate dehydrogenase complex
(spots 13 and 14). The core proteins of complex III (spots 4 and 5) and
the metabolic enzymes from the TCA cycle and pyruvate dehydroge-
nase complex presented higher nitration levels in IMF (1.6±0.3-,
35.1±11.2-, 23.6±9.8-fold, respectively; pb0.05) (Fig. 1 and Table 1).
NADH dehydrogenase 1 alpha subcomplex subunit 9 (spot 7),
succinate dehydrogenase ﬂavoprotein and iron-sulfur subunits (spot
11), cytochrome c oxidase subunit 4 (spot 9) and ATP synthase subunits
alpha and beta, gamma and f (spots 6, 7, 8 and 12) were found
carbonylated in both mitochondrial subpopulations. A PDQuest
evaluation of blotting data demonstrates the higher susceptibility
(pb0.05) of ATP synthase subunit beta, cytochrome c oxidase
polypeptide VIc-2 (spot 8) and ATP synthase subunit alpha (spot 9)
to carbonylation in SS mitochondria (24.3±5.1-, 32.2±8.3-fold,
respectively). Some of the detected proteins, particularly ATP synthase
subunits alpha and beta, were identiﬁed in several different spots, with
lower molecular weight than the intact proteins in both subpopula-
tions, suggesting a higher turnover of these complex V subunits.
Complementary analysis of trypsin digests from gel spots
corresponding to nitrated and carbonylated proteins was performed
by nano-LC/MS/MS. With this approach, in both subpopulations we
found oxidatively modiﬁed amino acid residues in NADH dehydroge-
nase 1 alpha subcomplex subunit 9, succinate dehydrogenase
ﬂavoprotein and iron-sulfur subunits, cytochrome b–c1 complex
subunit 2, cytochrome c oxidase polypeptide VIc, and in ATP synthase
subunits alpha and beta (Table 1). Among the modiﬁcations more
prevalent we found pyro-Glu and Met oxidation (Table 1). Some ofthese pyro-Glu modiﬁcations were located in particular domains of
respiratory chain complexes subunits. For instance, in cytochrome c
oxidase polypeptide VIc, the pyro-Glu observed was in the topological
domain of the mitochondrial intermembrane space, whereas in ATP
synthase subunit alpha was in the nucleotide-binding domain. Fig. 3
shows a representative MS/MS spectrum of the precursor ion at m/z
1399 attributed to the modiﬁed peptide 157FIHVSHLNASMK168 from
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9.
The hydroxylation at Lys168 (located in the Rossmann fold domain)
was conﬁrmed by the ions belonging to the a, b and y fragmentation
series, where there are no modiﬁcation for b series (until b11), but y1,
y7 and y8 present a 16-Da mass shift due to the conversion of C-
terminal lysine residue to hydoxylysine.
Regarding nitration, we screened the potential 3-nitrotyrosine-
containing peptides; however, no satisfactory MS/MS spectra were
obtained.
4. Discussion
When analyzing the impact of the mitochondria subcellular
location on membrane proteins' susceptibility to oxidative modiﬁca-
tions, overall our data showed higher levels of carbonylation in SS,
whereas mitochondria trapped within the contractile apparatus seem
more prone to nitration. Concomitantly, higher OXPHOS activity
levels were detected in IMF compared to SS mitochondria. Since no
signiﬁcant differences on OXPHOS complexes composition were
detected among subpopulations by PDQuest analysis of protein
spots' intensity in 2D-BN-PAGE gels (further conﬁrmed by Western
blotting of ATPB), distinct OXPHOS activity seems to reﬂect mem-
brane complexes' susceptibility to oxidative modiﬁcations. These
results are consistent with the idea that mitochondrial dysfunction
may be due to the higher susceptibility and/or accumulation of
oxidatively modiﬁed proteins [2,16,17]. Moreover, our results are in
agreement with the previous ﬁndings of Adhihetty et al. [10], that
reported, in skeletal muscle, higher ROS production and damage in SS
compared to IMFmitochondria. Indeed, though a natural consequence
Table 1
Nitrated (white lines) and carbonylated (grey lines) proteins identiﬁed in Western blots in cardiac SS and IMF mitochondria. Proteins for which modiﬁed peptides were found by nLC-MS/MS are signaled in bold.
Spot
#
Protein name UNIPROT
Accession no.
Protein MW Protein
pI
Peptide
count
dMass
(ppm)
Prec MW Theor MW Conf % OD ratio 2D BN 
Page (IMF/SS)
OD ratio blot 
(IMF/SS)
4721
56318.5
56318.5
56318.5
56318.5ATPB_RAT
ATPA_RAT
ATPB_RAT
ATPA_RAT
ATPA_RAT
ATPB_RAT
ATPB_RAT
ATPB_RAT
ATPB_RAT
ATPB_RAT
ATPB_RAT
ATPB_RAT
ATPA_RAT
ATP synthase subunit beta
4519
21
19
21
19
ATP synthase subunit alpha
ATP synthase subunit beta
ATP synthase subunit alpha
ATP synthase subunit beta
ATP synthase subunit alpha
ATP synthase subunit beta
ATP synthase subunit beta
ATP synthase subunit alpha
48
45
45
485.19
5.19
9.22
5
825.19
529.22
9.22
5.19
9.22
59716.6
59716.6
59716.6
59716.6
Cytochrome b-c1 complex subunit 1 QCR1_RAT 52815.4 5.57 12 34
Cytochrome b-c1 complex subunit 2 QCR2_RAT 48366.2 9.16 8 23
Cytochrome b-c1 complex subunit 2 QCR2_RAT 48366.2 9.16 8 23
Cytochrome b-c1 complex subunit 8 QCR8_MOUSE 9762.1 10.26 13 39
ATP synthase subunit gamma ATPG_RAT 30171.7 8.87 4 12
1399.72
1399.72
1399.72
1399.73
6Oxidation(K)@[12]
−5Oxidation(M)@[11]FIHVSHLNASMK
FIHVSHLNASMK
Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex
1401.711401.70−5Oxidation(M)@[2]IMNVIGEPIDER18105.1956318.5
319.9510337.4ATPK_MOUSEATP synthase subunit f
ATP synthase subunit beta
ATP synthase subunit beta
ATP synthase subunit beta
ATP synthase subunit beta
ATP synthase subunit alpha 
2712
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 10 
2511
991440.82 1440.83−5Oxidation(M)@[1]MALVGLGVSHSILK
QPVYVADVSK Gln->pyro-Glu@N-term −7 1088.56 1088.56 99
WLSSEIEETKPAK FormaldehydeAdduct(W)@1 −5 1529.77 1529.78 99
99
99
Cytochrome c oxidase polypeptide VIc-2 COX6C2_RAT 8455.0 10.07 6 21 QAGVFQSAK Gln->pyro-Glu@N-term −8 918.45 918.46 99
99
12 EAYPGDVFYLHSR Glu->pyro-Glu@N-term −5 1535.72 1535.72 99
EVAEQFLNIR Glu->pyro-Glu@N-term −6 1200.63 1200.64 99
NALANPLYCPDYR Carbamyl(C)@9; Dimethyl(R)@13 −5 1580.74 1580.75 99
QHLLGAGPHIK Gln->pyro-Glu@N-term −6 1153.64 1153.64 99
QPQELEFTK Gln->pyro-Glu@N-term −7 1102.53 1102.54 99
991217.61 1217.62−6
−13
−22
−3
−20
Lys-add@N-termVAEQFLNIR
3695.19
5.19
5.19
56318.5
56318.5
56318.5
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3 
ODO2_RAT 48894.4 8.89 1 3
Cytochrome c oxidase subunit 4 isoform 1 COX41_RAT 19502.1 9.45 9 24
NDUAA_RAT 40467.6 7.64 14 36
Cytochrome b-c1 complex subunit 8 QCR8_RAT 9843.2 10.52 5 15
NDUS3_MOUSE 30130.5 6.67 13 33
−1.5 ± 0.3 1.6 ± 0.3*
1.3 ± 0.4 −1.6 ± 0.2*
− 1.91 ± 0.8 − 24.3 ± 5.1*
1.6 ± 0.5 − 32.2 ± 8.3*
−1.9 ± 1.2 − 32.2 ± 8.3*
−1.2 ± 0.5 −1.6 ± 0.2*
−1.3 ± 0.4 1.56 ± 0.4
−1.4 ± 0.4 1.6 ± 0.3*
1.3 ± 0.4 1.56 ± 0.4
1.4 ± 0.3 1.56 ± 0.4
33
41
9
10 48366.2 9.16 15Cytochrome b-c1 complex subunit 2 QCR2_RAT
%
coverage
Sequence Modification
ATPA_RAT 59716.6 9.22 11
41785.9 9.77 16
8
6
7
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 9 NDUA9_RAT
1
2
3
4
Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit 
1399.781399.76Gln->Lys@[9]VSQLYGDLQHLK22126.7571569.7DHSA_RAT
1388.751388.75Oxidation(M)@[7]IYPLPHMYVIK
DLVPDLSNFYAQYK Oxidation (P)@[4]; Asp->Val@[5] 1671.81 1671.85 99
QQYLQSIEDR Gln->pyro-Glu@N-term 1 1261.59 1261.59 99
99
99
QQYLQSIEDREK Gln->pyro-Glu@N-term 0 1518.73 1518.73 99
YLGPAVLMQAYR Dethiomethyl(M)@[8] 1332.69 1332.72 99
12 33155.1956318.5
37148.9335660.8MDHM_RATMalate dehydrogenase
14
− 1.9 ± 0.6 − 2.9 ± 1.4*
3.2 ± 1.3* 23.6 ± 9.8*
− 1.8 ± 1.3 35.1 ± 11.2*
1.7 ± 0.8 −1.4 ± 0.642
13
11 Succinate dehydrogenase [ubiquinone] iron-
sulfur subunit
Dihydrolipoyl dehydrogenase DLDH_RAT 54004.1 7.96 9 29
Dihydrolipoyl dehydrogenase DLDH_RAT 54004.1 7.96 9 15
Isocitrate dehydrogenase [NAD] subunit alpha IDH3A_RAT 39588.0 6.47 10 16
DHSB_RAT 31808.9 8.96 14
⁎
pb0.05.
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Fig. 3. MS/MS spectrum of the peptide 157FIHVSHLNASMK168 derived from tryptic digestion of NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9 (accession #
NDUA9_RAT) which contains an oxidation (+16 Da mass shift) at the terminal lysine (indicated as K*). The b and y ion series are annotated.
1112 A.I. Padrão et al. / Biochimica et Biophysica Acta 1807 (2011) 1106–1113of aerobic life, the accumulation of carbonylated mitochondrial
proteins is undoubtedly associated with impaired respiratory func-
tion, playing a crucial role in the cellular response to physiopatho-
logical stimuli [12,16,17]. The comparative analysis of nitrotyrosine
levels (Table 1 and Figs. 1 and 2) suggests that the nitration of
mitochondrial complexes, particularly of complex III, did not affect
their function, since higher 3-NT levels were paralleled with an
increased OXPHOS efﬁciency noticed in IMF mitochondria. If these
modiﬁcations caused structural change(s), this did not affect their
function. Unlike carbonylation, the role of protein nitration in cell
physiology is unclear [27]. This posttranslational modiﬁcation occurs
as a consequence of the reaction of superoxide with NO, a cellular
messenger found in cardiac tissue, to produce the highly reactive
peroxynitrite anion that reacts with proteins generating nitrotyrosine
[12,14]. According to some authors [27,28], tyrosine nitration can be
selective, dynamic and reversible, leaving open the possibility of being
beneﬁcial as well as detrimental. For instance, protein nitration might
regulate electron transport chain (ETC) activity such that excessive
superoxide generation is blocked, buffering changes in oxygen
concentration [27]. Looking speciﬁcally to the protein targets of
nitration, the results do not support the deleterious effect of this
modiﬁcation on OXPHOS efﬁciency (Tables 1 and 2). This was
particularly evident for complex III, being core protein 1 and 2
preferential targets of RONS-induced posttranslational modiﬁcationsTable 2
Respiratory chain complexes activity in SS and IMF mitochondria, measured spectrophotom
Mitochondrial subpopulation NADH:ubiquinone oxidoreductase (U/g) Succinate:ub
reductase (μm
SS 56.7±7.6 186.2±23.4
IMF 68.5±10.4 222.8±10.1⁎
⁎ pb0.05.due to its location in the ETC process [16]. The metabolic enzymes
malate dehydrogenase, dihydrolipoyl dehydrogenase and isocitrate
dehydrogenase subunit alpha were found to be signiﬁcantly more
nitrated in IMF (Table 1), attenuating the deleterious effect of
increased superoxide anion produced [12,14] as a consequence of
the higher metabolic activity reported in this mitochondrial subpop-
ulation [11,18,29].
Among the other 12 distinct OXPHOS proteins identiﬁed as more
prone to carbonylation and/or nitration, the high susceptibility of
F1F0-ATP synthase stands out. Although not part of the ETC, its
location, as well as its abundance, makes it a prime candidate for
oxidative modiﬁcation [14,16]. During enzyme turnover, ATP
synthase goes through a sequence of coordinated conformational
changes of its major subunits [14]. The high susceptibility of ATP
synthase subunits alpha and beta to oxidation, together with the high
number of its fragments observed in 2D-BN-PAGE gels (Fig. 2 and
Table 1), supports the notion of an elevated turnover of complex V.
According to Choksi et al. [16], oxidative modiﬁcations of the alpha
and beta chains may alter their binding afﬁnity for complex V and
dissociation of both modiﬁed proteins from complex V may be a
protective function. The more than 20-fold increase in the carbonyl-
ation of ATP synthase subunits alpha and beta observed in SS
mitochondria is paralleled by lower activity in this subpopulation
(Table 2). The main carbonyl products of metal-catalyzed oxidation ofetrically.
iquinone
ol/min/g)
Cytochrome c reductase
activity (μmol/min/g)
Cytochrome c oxidase
(nmol/min/mg)
ATP synthase
(μmolPi/min/mg)
82.3±11.2 61.7±11.0 15.9±6.0
107.7±13.4 101.8±20.7 ⁎ 21.9±2.3
1113A.I. Padrão et al. / Biochimica et Biophysica Acta 1807 (2011) 1106–1113proteins, glutamic and aminoadipic semialdehydes usually related to
protein dysfunction [15], were not identiﬁed in the present study.
Apart from the amino acid residue found modiﬁed (pyro-Glu) in the
nucleotide binding domain of ATP synthase subunit alpha, no
evidence of oxidative modiﬁcations-induced structural changes was
noticed and warranted further investigation. Nevertheless, an
association between protein susceptibility to carbonylation and
decreased activity was noticed for the ETC complexes, whose subunits
were found more carbonylated in SS mitochondria.
In conclusion, our results show evidence of higher OXPHOS
activity in IMF compared to SS mitochondria; moreover, unlike
nitration, the overall effect of increased carbonylation of OXPHOS
complexes subunits may be an underlying mechanism of cardiac
mitochondria decreased functionality.
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